Iliad Research & Trading L.P. 13D and 13G filings for CardioGenics Holdings Inc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-02-26 11:25 am Unchanged | 2024-02-26 | 13G | CardioGenics Holdings Inc CGNH | Iliad Research & Trading L.P. | 2,415,275 9.990% | 0 (Unchanged) | Filing |
2023-02-14 10:24 am Unchanged | 2023-02-14 | 13G | CardioGenics Holdings Inc CGNH | Iliad Research & Trading L.P. | 2,415,275 9.990% | 0 (Unchanged) | Filing |
2022-02-07 4:51 pm Unchanged | 2022-02-07 | 13G | CardioGenics Holdings Inc CGNH | Iliad Research & Trading L.P. | 2,415,275 9.990% | 0 (Unchanged) | Filing |
2021-01-22 2:43 pm Unchanged | 2021-01-22 | 13G | CardioGenics Holdings Inc CGNH | Iliad Research & Trading L.P. | 2,415,275 9.990% | 0 (Unchanged) | Filing |